Literature DB >> 14662649

High blood pressure in acute stroke and subsequent outcome: a systematic review.

Mark Willmot1, Jo Leonardi-Bee, Philip M W Bath.   

Abstract

High blood pressure (BP) is common in acute stroke and might be associated with a poor outcome, although observational studies have given varying results. In a systematic review, articles were sought that reported both admission BP and outcome (death, death or dependency, death or deterioration, stroke recurrence, and hematoma expansion) in acute stroke. Data were analyzed by the Cochrane Review Manager software and are given as odds ratios (ORs) or weighted mean differences (WMDs) with 95% confidence intervals (CIs). Altogether, 32 studies were identified involving 10 892 patients. When all data were included, death was significantly associated with an elevated mean arterial BP ([MABP] OR, 1.61; 95% CI, 1.12 to 2.31) and a high diastolic BP ([DBP] OR, 1.71; 95% CI, 1.33 to 2.48). Combined death or dependency was associated with high systolic BP ([SBP] OR, 2.69; 95% CI, 1.13 to 6.40) and DBP (OR, 4.68; 95% CI, 1.87 to 11.70) in primary intracerebral hemorrhage (PICH). Similarly, high SBP (+11.73 mm Hg; 95% CI, 1.30 to 22.16), MABP (+9.00 mm Hg; 95% CI, 0.92 to 17.08), and DBP (+6.00 mm Hg; 95% CI, 0.19 to 11.81) were associated with death or dependency in ischemic stroke. Combined death or deterioration was associated with a high SBP (OR, 5.57; 95% CI, 1.42 to 21.86) in patients with PICH. In summary, high BP in acute ischemic stroke or PICH is associated with subsequent death, death or dependency, and death or deterioration. Moderate lowering of BP might improve outcome. Acute BP lowering needs to be tested in 1 or more large, randomized trials.

Entities:  

Mesh:

Year:  2003        PMID: 14662649     DOI: 10.1161/01.HYP.0000105052.65787.35

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  143 in total

Review 1.  Systemic blood pressure and stroke outcome and recurrence.

Authors:  Argye E Hillis
Journal:  Curr Atheroscler Rep       Date:  2004-07       Impact factor: 5.113

2.  Posterior reversible encephalopathy syndrome coexists with acute cerebral infarction: challenges of blood pressure management.

Authors:  Luji Liu; Lihong Zhang
Journal:  Quant Imaging Med Surg       Date:  2020-12

Review 3.  What Do Experimental Models Teach Us About Comorbidities in Stroke?

Authors:  Sunghee Cho; Jiwon Yang
Journal:  Stroke       Date:  2018-01-08       Impact factor: 7.914

Review 4.  Systemic blood pressure and stroke outcome and recurrence.

Authors:  Argye E Hillis
Journal:  Curr Hypertens Rep       Date:  2005-02       Impact factor: 5.369

Review 5.  What do we (not) know about the management of blood pressure in acute stroke?

Authors:  Annick Verstappen; Vincent Thijs
Journal:  Curr Neurol Neurosci Rep       Date:  2004-11       Impact factor: 5.081

6.  Intracerebral hemorrhage: clinical overview and pathophysiologic concepts.

Authors:  Fred Rincon; Stephan A Mayer
Journal:  Transl Stroke Res       Date:  2012-04-21       Impact factor: 6.829

Review 7.  Control of blood pressure in hypertensive neurological emergencies.

Authors:  Lisa Manning; Thompson G Robinson; Craig S Anderson
Journal:  Curr Hypertens Rep       Date:  2014-06       Impact factor: 5.369

8.  Late failure of cerebral autoregulation in hypoxic-ischemic encephalopathy is associated with brain injury: a pilot study.

Authors:  Zachary A Vesoulis; Steve M Liao; Amit M Mathur
Journal:  Physiol Meas       Date:  2018-12-07       Impact factor: 2.833

9.  Blood pressure declines and less favorable outcomes in the NINDS tPA stroke study.

Authors:  Brian Silver; Mei Lu; Daniel C Morris; Panayiotis D Mitsias; Christopher Lewandowski; Michael Chopp
Journal:  J Neurol Sci       Date:  2008-05-02       Impact factor: 3.181

10.  Early complications of ischemic stroke.

Authors:  H Bart van der Worp; T W M Dianne Raaijmakers; L Jaap Kappelle
Journal:  Curr Treat Options Neurol       Date:  2008-11       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.